News Roche, Lilly join forces on blood test for Alzheimer’s If approved, EAPP could help streamline the journey to diagnosis for patients, say partners.
News First major insurer covers Eisai’s Alzheimer’s drug Leqembi Department of Veterans Affairs will cover the drug for veterans with early-stage Alzheimer's.
News Lilly shares disappointing A4 study results for solanezumab The drug only targets soluble amyloid beta-protein and doesn't clear amyloid plaques.
News FDA sets July verdict date for Leqembi, after adcomm meeting After priority review, regulator will consider upgrading the drug's status to full approval.
News Leqembi still too pricey, says ICER in updated review Side effects create 'uncertainties' as to whether lecanemab's benefits exceed its risks.
News CMS accused of discrimination over Alzheimer’s drug verdict Decision not to revisit coverage decision for amyloid drugs is slammed by patient groups.
News Threat of Trump's pharma tariffs looms again The Trump administration is said to be preparing to announce tariffs of up to 100% on some pharmaceutical imports.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
